Canadian Cannabis Sales November Update
Canadian cannabis sales in November reached C$477.9 million, signaling a notable rebound. This figure rose 6.6 percent from October. However, per-day sales climbed even more at 10.2 percent because November had fewer days. Statistics Canada revised October sales to C$448.5 million, which affects month-over-month comparisons. As a result, year-over-year growth stood at 4.6 percent in November.
Regional patterns varied sharply across provinces, so the national picture masks local swings. For example, British Columbia bounced back strongly, while Ontario and Alberta cooled. Meanwhile, Quebec showed robust gains compared with last year. Analysts point to more stores and falling flower prices as key drivers. Therefore, retail recovery looks supported by both supply expansion and price dynamics.
This article unpacks the data, regional shifts, and what to watch next. Read on to understand November trends, implications, and the outlook for 2025. We also compare monthly revisions and spikes. Finally, we highlight risks and catalysts for growth.
Canadian cannabis sales in November: Volume, revenue and market trends
November showed a clear lift in sales volume and revenue. Canada recorded C$477.9 million in retail sales for November, a 6.6 percent increase from October. Per-day sales rose 10.2 percent because November had fewer days. October’s figures were revised down to C$448.5 million, which affects month-to-month comparisons. As a result, year-over-year growth was 4.6 percent.
Key November sales data and market trends
- Sales volume and revenue: National retail receipts reached C$477.9 million in November. This figure reflects both more transactions and steady pricing pressure on flower.
- Per-day performance: Per-day sales climbed 10.2 percent versus October, indicating stronger daily demand.
- Revisions and drivers: Statistics Canada revised October to C$448.5 million, and analysts note the October drop tied to a British Columbia strike. For the official release see Statistics Canada’s official release.
- Regional swings: British Columbia rebounded with a 250 percent sequential increase, while Ontario and Alberta posted month-on-month declines. Quebec improved strongly year over year.
- Structural factors: An increase in store counts and falling flower prices boosted sales, while competition from the illicit market remains a constraint.
- Trend context: November contributes to 2024 total sales of C$5.39 billion, and 2025 sales are up 4.2 percent so far.
For additional analysis, see New Cannabis Ventures and industry context at My CBD Advisor.
Table: Monthly comparison of Canadian cannabis sales metrics.
This compact table shows total sales, percent changes, per-day shifts, and top product categories. Note that some monthly totals are not publicly released.
| Month | Total sales (C$) | Month-on-month change | Year-over-year change | Per-day sales change | Top-selling product categories |
|---|---|---|---|---|---|
| November | C$477.9 million | +6.6% vs October | +4.6% YoY | +10.2% vs October | Flower; oils; edibles (flower prices falling) |
| October (revised) | C$448.5 million | n/a | n/a | n/a | Flower; oils; edibles |
| September | n/a | n/a | +6.2% YoY | n/a | Flower; oils; vapes |
| August | n/a | n/a | +20.3% YoY | n/a | Flower; vapes; concentrates |
Notes: October was revised by Statistics Canada to C$448.5 million. Meanwhile, November per-day growth reflects fewer days in the month.
What drove Canadian cannabis sales in November
Market conditions
- Retail momentum picked up in November, led by higher per-day demand. Because November had fewer days, per-day sales rose 10.2 percent. Meanwhile, national receipts hit C$477.9 million, up 6.6 percent from October. For official figures see Statistics Canada.
Consumer behavior and product mix
- Consumers shifted toward value and convenience, especially for flower and oils. As a result, falling flower prices boosted volumes. Edibles and concentrates held steady in niche segments. Older customers adopted legal channels more often, improving overall sales volume.
Regulatory and industry factors
- Store expansion increased legal availability and reduced illicit share. Therefore, more stores translated into higher retail transactions. October’s BC strike briefly limited supply, but November saw a strong rebound. Industry commentary and analysis appear at New Cannabis Ventures.
Economic influences
- Inflation and household budgets shaped buying patterns. However, steady pricing for many products eased cost pressure. Lower flower prices encouraged larger purchases per visit. As a result, revenue rose without proportional price inflation.
Provincial dynamics and short term shocks
- Provincial swings drove much of the national change. For example, British Columbia rebounded sharply after supply disruptions. Meanwhile Ontario and Alberta recorded month-on-month declines. Quebec showed strong year-over-year growth, altering the regional mix.
Implications and outlook
- Short-term gains look tied to availability and price moves. Therefore, watch store openings and flower pricing into December. The December data will clarify whether the recovery sustains into 2025.
In summary, Canadian cannabis sales in November reached C$477.9 million, reflecting a clear monthly rebound. Per-day sales rose 10.2 percent because November had fewer days, and overall receipts were up 6.6 percent from October. Year-over-year growth held at 4.6 percent, but provincial swings masked the national picture. For example, British Columbia posted a sharp sequential rebound, while Ontario and Alberta softened.
Staying current matters because short-term factors shape market direction. Watch store openings, shifts in flower pricing, and provincial supply disruptions. The December release on February 20 will show whether gains continue, and analysts will likely focus on per-day activity and product mix.
MyCBDAdvisor provides timely, evidence-based coverage to help readers interpret these trends. In addition, our resources include EMP0 as part of MyCBDAdvisor’s coverage for readers exploring cannabinoids. We aim to be a trusted source for CBD and cannabis information, combining data, industry context, and practical guidance.
Frequently Asked Questions (FAQs)
What were the headline figures for Canadian cannabis sales in November?
Canada recorded C$477.9 million in retail sales for November. This total rose 6.6 percent from October. Per-day sales climbed 10.2 percent because November had fewer days. Year-over-year growth was 4.6 percent. Note that Statistics Canada revised October to C$448.5 million, which affects month-to-month comparisons. For the official release see this link.
What key factors drove the November increase?
Multiple forces lifted sales in November. First, more store openings improved legal access and transaction counts. Second, falling flower prices boosted volumes, especially for value-seeking buyers. Third, British Columbia recovered after a strike in October, which restored supply. Finally, per-day metrics benefited from fewer days in November, so daily demand looks stronger. As a result, the combination of availability and price dynamics explains much of the gain.
Which provinces led or lagged in November?
Provincial results varied sharply. British Columbia saw a strong sequential rebound, rising roughly 250 percent from October and up about 9 percent year over year. Quebec posted robust year-over-year gains near 31 percent. Meanwhile Ontario and Alberta cooled, with Ontario down 5.2 percent from October and Alberta down 5.5 percent month on month. However Alberta remained slightly above last year. Therefore, regional swings drove much of the national story.
Which product categories performed best in November?
Flower remained the top-selling category by volume, followed by oils and edibles. Falling flower prices increased unit sales and encouraged larger baskets. Vapes and concentrates held niche demand, while edibles grew steadily in some provinces. In short, price-sensitive categories and broad availability shaped product mix.
What should readers watch next?
Watch the December sales release on February 20 for confirmation of the trend. Also monitor store openings, flower pricing, and short-term supply disruptions. For ongoing industry analysis, see commentary at New Cannabis Ventures. These signals will show whether the recovery sustains into 2025.
